| Cardiotoxicity of cancer therapy JD Floyd, DT Nguyen, RL Lobins, Q Bashir, DC Doll, MC Perry Journal of Clinical Oncology 23 (30), 7685-7696, 2005 | 512 | 2005 |
| Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation SO Ciurea, V Mulanovich, RM Saliba, UD Bayraktar, Y Jiang, R Bassett, ... Biology of Blood and Marrow Transplantation 18 (12), 1835-1844, 2012 | 289 | 2012 |
| Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and … A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ... Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014 | 256 | 2014 |
| Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma N Shah, L Li, J McCarty, I Kaur, E Yvon, H Shaim, M Muftuoglu, E Liu, ... British journal of haematology 177 (3), 457-466, 2017 | 181 | 2017 |
| Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation U Popat, RS Mehta, K Rezvani, P Fox, K Kondo, D Marin, I McNiece, ... Blood, The Journal of the American Society of Hematology 125 (19), 2885-2892, 2015 | 148 | 2015 |
| Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation TS Fenske, KW Ahn, TM Graff, A DiGilio, Q Bashir, RT Kamble, E Ayala, ... British journal of haematology 174 (2), 235-248, 2016 | 143 | 2016 |
| Fifty years of melphalan use in hematopoietic stem cell transplantation UD Bayraktar, Q Bashir, M Qazilbash, RE Champlin, SO Ciurea Biology of Blood and Marrow Transplantation 19 (3), 344-356, 2013 | 130 | 2013 |
| Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib M Sharma, F Ravandi, UD Bayraktar, A Chiattone, Q Bashir, S Giralt, ... Biology of Blood and Marrow Transplantation 17 (12), 1874-1877, 2011 | 127 | 2011 |
| Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results IF Khouri, RM Saliba, WD Erwin, BI Samuels, M Korbling, LJ Medeiros, ... Blood, The Journal of the American Society of Hematology 119 (26), 6373-6378, 2012 | 113 | 2012 |
| Durable remission with salvage second autotransplants in patients with multiple myeloma N Shah, F Ahmed, Q Bashir, S Qureshi, Y Dinh, G Rondon, S Wen, P Thall, ... Cancer 118 (14), 3549-3555, 2012 | 85 | 2012 |
| Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched … S Gaballa, I Ge, R El Fakih, JE Brammer, P Kongtim, C Tomuleasa, ... Cancer 122 (21), 3316-3326, 2016 | 80 | 2016 |
| Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial Q Bashir, PF Thall, DR Milton, PS Fox, JD Kawedia, P Kebriaei, N Shah, ... The Lancet Haematology 6 (5), e266-e275, 2019 | 79 | 2019 |
| Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study MA Kharfan‐Dabaja, MM Al Malki, U Deotare, RV Raj, N El‐Jurdi, ... British journal of haematology 179 (5), 781-789, 2017 | 77 | 2017 |
| Feasibility of autologous hematopoietic stem cell transplant in patients aged≥ 70 years with multiple myeloma Q Bashir, N Shah, S Parmar, W Wei, G Rondon, DM Weber, M Wang, ... Leukemia & lymphoma 53 (1), 118-122, 2012 | 77 | 2012 |
| Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis AS Kanate, A DiGilio, KW Ahn, M Al Malki, E Jacobsen, A Steinberg, ... British journal of haematology 182 (6), 916, 2018 | 75 | 2018 |
| Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome SO Ciurea, MV Shah, RM Saliba, S Gaballa, P Kongtim, G Rondon, ... Biology of Blood and Marrow Transplantation 24 (6), 1232-1236, 2018 | 74 | 2018 |
| Early post-transplant minimal residual disease assessment improves risk stratification in acute myeloid leukemia MV Shah, JL Jorgensen, RM Saliba, SA Wang, AM Alousi, BS Andersson, ... Biology of Blood and Marrow Transplantation 24 (7), 1514-1520, 2018 | 73 | 2018 |
| Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation RS Mehta, RM Saliba, J Chen, G Rondon, AE Hammerstrom, A Alousi, ... British journal of haematology 173 (3), 444-455, 2016 | 73 | 2016 |
| Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations SO Ciurea, A Chilkulwar, RM Saliba, J Chen, G Rondon, KP Patel, ... Blood, The Journal of the American Society of Hematology 131 (26), 2989-2992, 2018 | 72 | 2018 |
| Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome Y Nieto, U Popat, P Anderlini, B Valdez, B Andersson, P Liu, C Hosing, ... Biology of Blood and Marrow Transplantation 19 (3), 410-417, 2013 | 72 | 2013 |
Yago NietoProfessor of Medicine, The University of Texas MD Anderson Cancer CenterE-mail confirmado em mdanderson.org
